ServicenavigationHauptnavigationTrailKarteikarten

Research unit
INNOSUISSE
Project number
29722.1 IP-LS
Project title
Molecular target validation and profiling of a novel class of anti-triple-negative breast cancer (TNBC) small-molecule Wnt pathway inhibitors.
Project status Finished
 
Start date 01.10.2018
End date 01.02.2021
 
Granted total costs 265'885.49  CHF
Section 60 Life Sciences
Project category Project
Research type Applied research and development
NABS classification Industrial production and technology
 
Research disciplines
100 % T410 Pharmaceuticals and related technologies
Last modification of the project